Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
Kaoru Yamabe Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Chuou-ku, Tokyo, JapanThis series presents articles using data collected from the National Health and Wellness Survey1 in Japan to assess the burden of inflammatory bowel disease (IBD), multiple sclerosis (MS), and dep...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-10-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/health-related-outcomes-and-economic-burden-in-japan-focus-on-inflamma-peer-reviewed-article-CEOR |